Have you heard of this “Income Glitch”?

Have you heard of the "Income Glitch" this unique trader has discovered on one individual stock? Unsubscribe A Message from DTI Have you heard of the “Income Glitch” this computer whiz has discovered on one little-known ticker? He’s been making out like a bandit with a 100% success rate on over 52 trade opportunities!  Take a look at this…  Let’s say you had $10k stashed away in a high-yield savings account at the beginning of 2023 - You’d have a whopping $277 profit.  What about the S&P 500 after its heck of a rally this year? You wouldn’t even be up two grand.  But that same starting stake using the “Income Glitch” over the last seven months could have brought in… As you can see, the wins really add up quick without a single loser!  Of course no one can guarantee future performance or against losses… but if you want in on what could be the 53rd straight win in a row… Go here to watch the “Income Glitch” workshop for free By clicking the link above you agree to periodic updates from DTI and its partners (privacy policy) All the best

This message is a paid advertisement sent on behalf of DTI, a third-party advertiser of MarketBeat. Why did I receive this email?     The profits and performance shown are not typical, we make no future earnings claims, and you may lose money. From 6/28/22 to 7/27/23, the win rate is 100% over 52 published alerts. The average return is 7.26% with an average hold of 14 days. Annualized return on options is 242.98% per year without compounding.     If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.   If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.   © 2006-2023 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.   Today's Bonus Content: 6.5 Million Americans Are DESPERATE for This New Drug from One Tiny Company